CESAR Programme. Qualification for providing smoking cessation service in Spanish community pharmacies
M Cano 6
More details
Hide details
Community Pharmacist,Barcelona, Spain
Community Pharmacist, San Sebastián de los Reyes, Spain
Community Pharmacist, Reus, Spain
Department of Preventive Medicine, Hospital Universitari de Bellvitge, Spain
Community Pharmacist, Palma de Mallorca, Spain
Community Pharmacist, La Nucia, Spain
Publication date: 2018-06-13
Corresponding author
S Navidad   

Community Pharmacist, San Sebastián de los Reyes, Spain
Tob. Prev. Cessation 2018;4(Supplement):A185
Community pharmacists must participate in prevention activities that promote public health and prevent disease. Smoking in Spain reaches a prevalence of 24%, causing high rates of morbimortality. Pharmacists play an important role in dealing with smoking. SEFAC has launched different training programs to implement pharmaceutical services, one of which is the CESAR program, Objectives: To offer a qualification to community pharmacists and promote training and practice. To provide tools and interventional strategies to deal with patients who smoke. To evaluate the number of pharmacists participating in the training, the attendees to the face-to-face sessions and the number of patients included and the successful at six months.

A descriptive, transversal and retrospective research. CESAR program consists in an online course, a face to face practical workshop given by pharmacists and physicians on the implementation and management of smoking cessation service in community pharmacy and a record of clinical cases in a website. A consensus document with Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), Spanish Society of Family and Community Medicine (semFYC), Spanish Society of Primary Care Doctors (SEMERGEN), Spanish Society of Family Doctors and General Practitioners (SEMG) and Spanish Society of Smoking Specialists (Sedet) was designed to refer to physician.

As of January 2018, there were 1660 registered pharmacists. The online course has exceeded 703, the face-to-face sessions 1757 (in 27 workshops) and 1329 clinical cases have been registered. 434 cases are in follow-up, 191 have left the program and 704 have already passed the six months of follow-up (634 continued without smoking and 70 had relapsed).

There is a demand for training among community pharmacists to help patients to stop smoking. The successful cases compared with those who withdrew indicate that the CESAR programme could be a useful instrument for promoting smoking cessation through community pharmacies.

Journals System - logo
Scroll to top